
|Articles|December 1, 2004
- Volume 0 0
Workload Leads to Less Sleep
Advertisement
The American Time-Use Survey released by the Bureau of Labor Statistics revealed that more work leads to less sleep. The purposeof the survey was to estimate how Americans spend their time. The findings showed that nonworking individuals sleep morethan those who are employed (9.1 hours/night vs 8.3 hours/night). Additionally, the data indicated that individuals with multiple jobssleep less, compared with individuals holding a single job (7.9 hours/night vs. 8.3 hours/night).
Articles in this issue
almost 22 years ago
Treatment of Patients with Atrial Fibrillationalmost 22 years ago
Understanding and Managing Polypharmacy in the Elderlyalmost 22 years ago
Counterfeit Drugs: A Real Cause for Alarmalmost 22 years ago
New Treatments on the Way for Diabetes-Part 1almost 22 years ago
Effective Counseling for Patients with Hypertensionalmost 22 years ago
Preventing and Managing Thrombosis with Anticoagulantsalmost 22 years ago
RxPRODUCT NEWS: PROFILE: Cardizem LA (diltiazem hydrochloride)almost 22 years ago
Staying Well with Herbs and Vitaminsalmost 22 years ago
Health Professional Imposters-Part 1Advertisement
Related to this article

Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.

A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.

Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.

The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
Influenza Vaccines Continue to Reduce Severe Disease and Death Across High-Risk Groups, Evidence Review Finds
4
Building a BCMA Bispecific Around the Patient Experience, Not Just the Molecule
5



